A Retrospective Observational Study Evaluating Changes In Glycemic Control In Adult Patients With Type 2 Diabetes Mellitus (T2DM) and Treated With Canagliflozin Using The Inovalon MORE2 (Medical Outcomes Research for Effectiveness and Economics) Registry Database.
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2015
At a glance
- Drugs Canagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 01 Jun 2015 New trial record
- 20 May 2015 Results presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.